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The survival, proliferation, self-renewal and differentiation of
human pluripotent stem cells (hPSCs, including human
embryonic stem cells and human induced pluripotent stem
cells) involve a number of processes that require cell-cell and
cell-matrix interactions. The cell adhesion molecules (CAMs), a
group of cell surface proteins play a pivotal role in mediating
such interactions. Recent studies have provided insights into
the essential roles and mechanisms of CAMs in the regulation
of hPSC fate decisions. Here, we review the latest research
progress in this field and focus on how E-cadherin and several
other important CAMs including classic cadherins, Ig-
superfamily CAMs, integrins and heparin sulfate proteo-
glycans control survival and differentiation of hPSCs
Introduction
Our understanding of the molecular and cellular mechanisms
that control self-renewal and pluripotency of human pluripotent
stem cells and our progress toward harnessing the regenerative
potential of these cells to treat human diseases are advancing at a
rapid rate. Human pluripotent stem cells include human
embryonic stem cells (hESCs) and human induced pluripotent
stem cells (hiPSCs). The first hESCs were generated in 1998 from
the inner cell mass of blastocyst-stage embryos.
1 Their unique
capacity for indefinite self-renewal (unlimited proliferation) in
vitro coupled with their ability to differentiate into almost any cell
type present in the adult body (pluripotency) provide a potentially
unlimited source of cells for cell replacement therapies. The
demonstration, in 2007, that hiPSCs could be generated from
human fibroblast cells has further expanded this therapeutic
potential.
2,3 Like hESCs, hiPSCs are capable of differentiating
into almost any tissue type in the body.
2-8 Production of hiPSCs,
therefore, have been hailed as a transformative breakthrough in
regenerative medicine with potential to lead to disease-based
modeling and patient-tailed therapies. Clearly, understanding the
mechanisms that control self-renewal, pluripotency and differen-
tiation of hESCs and hiPSCs is key to realizing this potential and
validating new therapies for many human degenerative diseases
that currently have no cure.
Our understanding of the regulatory networks underlying
the initiation and maintenance of hESC and hiPSC self-renewal
and pluripotent states has expanded considerably during the past
14 years. Key transcription factors, including Oct4, Sox2 and
Nanog, have been found to act in autoregulatory modules to
specify the pluripotent state of both mouse and human pluri-
potent stem cells.
9 Other regulatory cues, such as supporting
cells,
1,10,11 extracellular matrix,




19-23 and various signaling path-
ways
24-29 have also been extensively studied and their relevance
in self-renewal and differentiation of human pluripotent stem cells
is now well recognized. However, the long-standing question as to
why hESCs are so sensitive to the disruption of cell-cell contact,
undergoing massive cell death when dissociated into single cell
suspensions has only begun to be understood in recent years,
which is key to propagating sufficient numbers of hESCs and
hiPSCs for regenerative therapy.
A growing number of reports now reveal that, in addition to
the support cells, extracellular matrix and growth factor cues, cell
adhesion molecule (CAM)-mediated cohesive interaction among
hESCs (and hiPSCs) and between the cells and their neighboring
instructive/support cells and extracellular matrix contribute signi-
ficantly to the self-renewal and the pluripotent state of human
pluripotent stem cells. CAMs are the proteins on the surface of
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mammalian cells that contribute to juxtacrine cell-cell binding or
cell-matrix binding. Two decades of structural biology studies
have characterized domain topologies and binding mechanisms
at the molecular/atomic level for key members of all the main
classes of CAMs: the cadherins, integrins, selectins and immuno-
globulin superfamily (IgSF).
30 Cell biology approaches have
shown that CAMs perform a wide range of functions at cell-cell
and cell-matrix interfaces, such as mechanical support, target
recognition, cell differentiation, initiation and regulation of signal-
ing platforms, etc.
30 Notably, numerous CAM family members
have recently been identified on the surface of human pluri-
potent stem cells and found to regulate their self-renewal and
pluripotency.
12,31-35
This review will summarize recent progress in the study of
CAM function in human pluripotent stem cells. We will focus
on the roles of E-cadherin and several other molecules from
following CAM superfamilies: the cadherins (N-cadherin and
VE-cadherin), the integrins and the IgSF CAMs. In addition, we
will also briefly discuss the significant role of heparin sulfate
proteoglycans (HSPGs), a group of cell-matrix adhesion molecules
critical in mediating the interaction between human pluripotent
stem cells and extracellular matrix, in the regulation of hESC
and hiPSC fate.
Cell-Cell Adhesion Molecules in Human Pluripotent
Stem Cells: E-, N- and VE-Cadherins
The cadherin superfamily is comprised of more than 100
members in vertebrates and can be further divided into classic
and non-classic subfamilies. Cadherins were originally identified
as cell surface glycoproteins responsible for Ca
2+-dependent
homophilic cell-cell adhesion during morula compaction in the
preimplantation mouse embryo and during chick development
in the early 1980s.
36-39 In the three decades since their discovery,
it has become clear that the role of cadherins is not limited to
mechanical adhesion between cells. While beyond the scope of
this review, the history, general features, structure and model of
homophilic binding of cadherin have already been reviewed
extensively in a number of different contexts.
30,40
Among the classic cadherin subfamily, the roles of E-cadherin,
N-cadherin and VE-cadherin have been mostly studied in human
pluripotent stem cells. These three classical cadherins were
originally named for the tissue in which they were prominently
expressed: epithelial cadherin (E-cadherin) in skin epithelia,
neural cadherin (N-cadherin) in the central nervous system and
vascular endothelial cadherin (VE-cadherin) in blood vessel endo-
thelia. Our current understanding of how these three classical
cadherins modulate hESC phenotype is described below.
The molecular structure and the binding sites of E-cadherin.
E-cadherin is a transmembrane glycoprotein that mediates
calcium-dependent, homophilic cell-cell adhesion in all epithelial
tissues including embryonic stem cells.
40 As shown in Figure1,
E-cadherin has long extracellular and cytoplasmic domains. The
extracellular domain of E-cadherin establishes homophilic inter-
actions between neighboring cells, while its cytoplasmic tail
associates with an array of multifunctional adaptor proteins. These
intracellular adaptor proteins link cell-cell adhesion to the actin-
myosin network and other intracellular signaling pathways.
The cytoplasmic part of E-cadherins contains binding sites for
two catenins, p120-catenin and β-catenin. While p120-catenin is
involved in the delivery and stabilization of adhesion complexes
at the plasma membrane,
41-43 β-catenin provides the connection to
a-catenin. The a-catenin complex in turn interacts with formin to
nucleate actin filaments at the adherens junctions and uses an
unknown mechanism to link cadherin-catenin complexes at the
membrane with the actin cytoskeleton.
44-46 Strengthening of
E-cadherin-mediated cell-cell adhesion is dependent on intact actin
cytoskeleton, which includes motor protein non-muscle myosin
(NM) II. The NM II motor protein is a hexamer of three subunits
(two heavy chains with a globular N-terminal motor domain for
each, two regulatory light chains and two essential light chains) that
converts the energy from ATP hydrolysis into mechanical work and
is post-translationally regulated by the phosphorylation of its light
and heavy chains.
47 In addition to linking cadherin and a-catenin
withthe actin-myosin cytoskeleton, β-cateninisalsoa centralpartof
thecanonicalWntsignaling pathway.
48 Themolecular structureand
the binding sites of E-cadherin, and its connection with the actin-
myosin network, are illustrated in Figure1A.
Figure1 (See opposite page). E-cadherin and its associated molecules in the survival and differentiation of human embryonic stem cells. (A) The
molecular structure and the binding sites of E-cadherin and its connection with actin cytoskeleton. The extracellular region of E-cadherin consists of five
cadherin-type repeats (extracellular cadherin domains) that are bound together by Ca
2+ ions. The cytoplasmic tails of E-cadherin bind to p120-catenin
(p120) and b-catenin (b-cat), while b-catenin binds to monomeric a-catenin (a-cat) which indirectly anchors the cadherin-catenin complexes to the actin
filaments (F-actin). NM II molecules assemble into bipolar filaments by interactions between their rod domains. These filaments bind to actin through
their head domains where the ATPase activity enables a conformational change that moves actin filaments in an anti-parallel manner. (B) Schematic view
of the pathways associated with E-cadherin in the survival of human embryonic stem cells. (i) Cooperation between E-cadherin and the actin
cytoskeleton and Rho family GTPases in the regulation of survival of dissociated human embryonic stem cells (hESCs). The subunit of non-muscle myosin
II (NM II) forms a dimer through interactions between the a-helical coiled-coil rod domains. The globular head domain contains the actin-binding regions
and the enzymatic Mg2+-ATPase motor domains. The light chains bind to the heavy chains at the lever arms that link the globular head and rod
domains. Dissociation of hESCs results in disruption of E-cadherin mediated cell-cell adhesions and subsequently leads to Rho/ROCK activation and
phosphorylation of myosin light chain. Y-27632 inhibits ROCK activation and therefore suppresses the phosphorylation of myosin light chain and
promotes the survival and cloning efficiency of hESCs. Blebbistatin inhibit heavy chains and facilitate survival of dissociated hESCs. (ii) Regulation of
E-cadherin expression in hESCs via molecular turnover and membrane trafficking. Unlike epithelial cells, hESCs lack a negative feedback-like mechanism
between Rap1 and E-cadherin. After disassembly of adherens junctions, Rap1 is delivered to lysosomes and degraded, which further hampers hESC
clonogenicity. There is another unique positive feedback loop between p120-catenin (p120) and E-cadherin in hESCs. Unlike epithelial cells, E-cadherin
increases p120 production, while p120 boosts E-cadherin expression. p120 seems to facilitate E-cadherin accumulation at cell-cell junctions, thereby
enhancing the self-renewal of hESCs.
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The role of E-cadherin in hESCs. As one of the archetypal
cadherin families, E-cadherin is essential for epithelialization of
the early mouse embryo, cell rearrangement, tissue morpho-
genesis, establishment of cell polarity and maintenance of tissue
architecture.
40 Given the inherent origin of undifferentiated
hESCs (derived from the inner cell mass of the blastocyst
1 wherein
E-cadherin was found on human oocytes and early embryos
49),
one may speculate that E-cadherin expression reflects the tissue of
origin from which the hESCs are initially derived and, as such,
that E-cadherin mediated cell-cell cohesion plays an important
role in the survival and self-renewal of hESCs. Indeed, E-cadherin
has been used as an undifferentiated marker to identify hESCs.
E-cadherin is co-expressed with other typical undifferentiated
markers, such as SSEA4, Tra-1-60, Tra-1-81, alkaline phospha-
tase, as well as pluripotency factors Oct4 (also known as Pou5f1),
Nanog and Sox2 in undifferentiated hESCs.
21,50-52 The use of
E-cadherin to demarcate differentiated and undifferentiated
hESCs is based on definitive expression kinetics. Expression in
undifferentiated hESCs is decreased immediately after induction
of differentiation.
50,51 The positive expression of E-cadherin in
Figure1. For figure legend, see page 61.
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characteristic colonies is usually considered as one of the
undifferentiated properties during the hESC maintenance.
21,53,54
Accordingly, in the recent derivation of iPSCs from somatic cells,
development of compact colonies with tight cellular association
and E-cadherin expression has been used and is now widely
accepted as a simple and reliable readout for conversion of non-
ESCs to an ESC-like state.
2,3,55,56
Beyond use as a supplementary marker for undifferentiated
hESCs,
21,50-52 the active role of E-cadherin in hESC self-renewal
was not further pursued until recently. One potential explanation
for this might be a clear demonstration in 1996 that E-cadherin
was dispensable for mouse ESC maintenance.
57 More recent
studies, however, report that hESCs may resemble mouse epiblast
stem cells (EpiSCs)
58,59 to a greater extent rather than mouse ESCs
in their molecular profile and growth factors requirements.
60,61
Intriguingly, a current report described a mouse EpiSC-like cell
type, termed FAB-SCs (i.e., fibroblast growth factor, Activin
and BIO-derived stem cells),
62 that share expression markers
with EpiSCs but are unable to differentiate. Remarkably, these
differentiation-resistant FAB-SCs can be steered to convert into
their naïve pluripotent state (like ESCs) by ectopic expression of
E-cadherin, suggesting an unexpected role for E-cadherin-
mediated cell-cell adhesions in the maintenance of pluripotent
state.
62 Taken together, the molecular and biological similarities
between hESCs and mouse EpiSCs indicate that E-cadherin
corresponds, at least partially, to the survival, self-renewal and
pluripotency state of hESCs.
Recent reports from several groups, including our own, have
indeed demonstrated that E-cadherin directly contributes to
hESC survival and self-renewal.
22,32,63-66 Unlike mouse ESCs,
dissociated hESCs are highly susceptible to apoptosis and under-
go massive cell death upon seeding as single cells at low cell
density
21,67 or in suspension culture.
63 Several lines of evidence
recently suggest that the primary cause of hESC death follow-
ing cell dissociation comes from an irreparable disruption of
E-cadherin signaling.
22,32,63-66,68 Even attenuation of E-cadherin
interactions will cause hESC blebbing and apoptosis, such as
treatment with a Ca
2+ chelator, incubation with an E-cadherin
blocking antibody, or knockdown E-cadherin with siRNA or
shRNA.
64-66 Conversely, timely reestablishment of E-cadherin-
mediated cell-cell contact (within temporal windows of interven-
tion) facilitates survival and proliferation of dissociated single
hESCs.
32,63,69 At a high plating-density, single hESCs can
reaggregate together via cell motility and reestablish cell-cell
contacts and form typical undifferentiated polyclonal colonies.
32,63
Such motility-induced reaggregation occurred very often (~70%)
if the distance between two single hESCs was , 6.4 mm and very
rarely if the distance was . 150 mm. As a result, if single hESC
could not efficiently reaggregate together at a low plating density,
they would lose E-cadherin and alkaline phosphatase expression,
eventually undergoing cell death or differentiation.
63 Consistently,
2,4-disubstituted thiazole, a small molecule capable of stabilizing
E-cadherin after cell dissociation, was shown to reduce hESC
death.
22 Together, these results suggest that E-cadherin-mediated
cellular adhesion plays a determinative role in the control of hESC
death or survival after dissociation.
In addition to modulating survival and proliferation,
E-cadherin also contributes to the self-renewal and pluripotency
of hESCs. Upregulation of E-cadherin expression markedly
enhances the cloning efficiency and self-renewal capacity of
hESCs.
63 Further, small molecules capable of upregulating
E-cadherin expression facilitate hESC self-renewal.
22 Conversely,
inhibition of E-cadherin expression with specific blocking anti-
body suppresses hESC self-renewal
32,66 and results in not only an
altered response to growth factor stimulation but also an overall
decrease in hESC proliferation.
51 Moreover, suppression of E-
cadherin expression by siRNA or by blocking antibodies lead to
a rapid loss in the expression of pluripotency markers Oct4,
Nanog and Sox2 in hESCs.
32,66 Oct4, Nanog and Sox2 constitute
a core set of transcription factors crucial for the maintenance of
pluripotent state of ESCs.
70,71 It has yet to be established how (or
indeed if) signaling events downstream of E-cadherin connect
with these core set of transcriptional factors.
Taken together, the aforementioned findings yield a conclusion
that E-cadherin is not only a marker for undifferentiated hESCs
but also actively contributes to the death/survival, self-renewal
and pluripotent state of hESCs.
22,32,63-66
Molecular mechanisms underlying the role of E-cadherin
in hESCs. Recent studies have identified multiple regulatory
mechanisms involved in the interplay between E-cadherin and
cell signaling in the regulation of cell fate decisions of hESCs.
As illustrated in Figure1B, several key mechanistic elements
participate in a range of regulatory events in hESCs, such as
cooperation between E-cadherin and the actin cytoskeleton and
Rho family GTPases,
63-66,72 regulation of E-cadherin expression at
the hESC surface by turnover and membrane trafficking
32,66 and
interplay between E-cadherin and cell signaling.
22,32,51,69
Cooperation between E-cadherin and the actin cytoskeleton and
Rho family GTPases. Increasing evidence has shown that the
activity of NM II motor protein, a major component of actin
cytoskeleton, is involved in (or regulates) the survival and self-
renewal of hESCs, likely through E-cadherin.
64-66,72 These studies
have demonstrated that NM II exhibits dual functions in
hESCs.
64,65,72 For hESC colonies where E-cadherin-mediated
cell-cell contacts have been established, NM II may help stabilize
Oct4-Nanog-Sox2 circuitry possibly by regulating E-cadherin-
mediated intercellular adhesion and by stabilizing p120-catenin
protein.
66 For dissociated single hESCs, NM II may accelerate
the apoptosis of single hESCs through the Rho-Rock (Rho-
associated kinase)-Myosin signaling axis.
64,65,72,73
For hESC colonies, NM II forms a network with E-cadherin
and p120-catenin. This regulatory network helps hESCs remain
in close contact and thus maintain their undifferentiated con-
ditions.
66 NM II, the two-headed conventional myosin, consists
of three isoforms, IIA, IIB and IIC.
74 The isoform IIA and IIB
(not IIC) are predominantly localized to plasma membranes, and
NM IIA has been observed to colocalize with E-cadherin in
undifferentiated hESCs.
66,72 Depletion of NM IIA (but not NM
IIB), or treatment with blebbistatin (a small molecule specifically
inhibiting the myosin heavy chain ATPase), reduces E-cadherin
accumulation at the junctional sites and impairs the formation
of characteristic hESC colonies. As a result, a great number of
62 Cell Adhesion & Migration Volume 6 Issue 1© 2012 Landes Bioscience.
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hESCs within the colonies can be dissociated from one another
and spread out as single cells. Moreover, those hESC cells also
show lower levels of alkaline phosphatase activity and lower level
expressions of Sox2, Nanog and Oct4 proteins, indicating an
impaired status of self-renewal. This study suggests that NM IIA
is necessary for the formation of E-cadherin-mediated cell-cell
contacts and that E-cadherin is essential for the formation of
characteristic hESC colonies, for the stability of the Oct4-Nang-
Sox2 circuitry and for the long-term survival of hESCs.
On the other hand, for dissociated single hESCs, blebbistatin
treatment or selective knockdown of myosin heavy and light
chains (or knockdown of ROCK1 or ROCK2) reduces apoptosis,
promotes the expression of Oct4 and Nanog and enhances the
survival and self-renewal of the dissociated hESCs.
64-66,72,73
Three independent groups have recently elucidated a basic
molecular mechanism regarding ROCK-dependent cell death in
hESCs.
64,65,72 Using multidisciplinary approaches (e.g., Ca
2+
chelator EGTA to disrupt the cadherin-mediated cell attach-
ment, E-cadherin-blocking antibodies, siRNA knockdown,
FRET analysis, etc.), Ohgushi and colleagues
65 found that the
continuous loss of E-cadherin-dependent intercellular adhesion
was responsible for blebbing and apoptosis of hESCs. Apoptosis
was induced by actomyosin hyperactivation and triggered by the
loss of E-cadherin-dependent intercellular contacts following
ROCK activation. Further support has been provided by Chen
and colleagues
64 who observed that ROCK inhibition suppresses
the phosphorylation of myosin light chain and promotes the
cloning efficiency of hESCs, possibly by hampering actin-myosin
contraction. It has been suggested that Rho activation coupled
with Rac inhibition is a driver for dissociation-induced hESC
apoptosis via ROCK-mediated myosin light chain phosphoryla-
tion. The Abr (actin binding region)-dependent “Rho-high/
Rac-low” state may play a decisive role in initiating the
dissociation-induced actomyosin hyperactivation and apoptosis
in hESCs.
65 Therefore, the actomyosin machinery downstream
of Rho activation plays an important role in cell blebbing
and apoptosis after hESC dissociation. This may explain why
a selective ROCK inhibitor (Y-27632) exhibits a significant
anti-apoptotic effect on dissociated single hESCs that was first
reported in 2007.
21
Regulation of E-cadherin expression in hESCs via molecular
turnover and membrane trafficking. The dynamic properties of
E-cadherin molecule and its complexes are observed both in
vivo in Drosophila embryos
75,76 and in vitro in epithelial cell
culture.
77-79 A pivotal role for various membrane trafficking
pathways in regulating cellular transitions between quiescent
adhesive states and more dynamic phenotypes have been
reported.
80-83 Regulation of E-cadherins expression by mem-
brane trafficking is emerging as a key player in hESC self-renewal,
and studies are also beginning to reveal how this process occurs.
It is apparent that endocytic recycling pathway involves the
formation and maintenance of E-cadherin-mediated cell-cell
cohesion in hESCs. A temporal interplay between the small G
protein Rap1 and E-cadherin serves as a timely and efficient
mechanism to regulate hESC self-renewal.
32 Rap1 is a member
of the Ras family of small G proteins.
84 Rap1 is co-localized
with E-cadherin on hESC membrane and also localized to the
perinuclear region, which is required for the proper delivery of
E-cadherin to the nascent cell-cell contact sites in hESCs.
32
Rap1 impacts hESC clonogenicity by affecting the initiation and
formation of E-cadherin mediated cell-cell contacts. In turn, the
inadequate formation of E-cadherin-mediated cell-cell adhesion in
hESCs exacerbates the diminution of E-cadherin by accelerating
Rap1 degradation, which further hampers the clonogenic capacity
and self-renewal of hESCs.
32 Unlike epithelial cells,
85-87 hESCs
lack a negative feedback-like mechanism between Rap1 and
E-cadherin. After disassembly of adherens junctions, Rap1 is
delivered to lysosomes and degraded, which further hampers
hESC clonogenicity. Thus, hESC dissociation to reseeding should
be completed within 30 min to limit Rap1 delivery to the
lysosome.
32,63 It can be concluded that a functional crosstalk
between Rap1 and E-cadherin along the endocytic recycling
pathway contributes to the self-renewal of hESCs.
In addition, p120-catenin has recently received a great
attention in cadherin trafficking.
30 A role of p120-catenin in
stabilizing cadherin junctions has been observed previously in
epithelial tumor cell lines
41,42 and in endothelial cells.
43 Loss of
p120 results in an increase in turnover rate of E-cadherin has
been observed in epithelial cells.
88 In hESCs, however, E-cadherin
and p120-catenin uniquely work in a positive feedback loop:
E-cadherin increases p120-catenin production, while p120-
catenin boosts E-cadherin expression. p120-catenin seems to
facilitate E-cadherin accumulation at cell-cell junctions, thereby
enhancing the self-renewal of hESCs.
66 It should be noted that
E-cadherin dynamics and trafficking is a relatively new topic in
hESCs. The ability for individual E-cadherin molecule or com-
plexes to be continually formed and disassembled is vital for the
preservation of hESC property and colony integrity during cell
proliferation and colony reorganization and requires further
investigation.
The interplay between E-cadherin and cell signaling. In addition
to Rho family small GTPases,
64-66,72 small G protein Rap1
32 and
the p120-catenin,
66 the interplay between E-cadherin and other
signaling molecules is also important for the regulation of hESC
fate. Xu and colleagues
22 discovered that the primary cause of
hESC death following enzymatic dissociation comes from an
irreparable disruption of E-cadherin signaling, which leads to a
fatal perturbation of integrin signaling. Furthermore, they found
that cultivating hESCs under conditions that favor mouse ESC
growth (e.g., in the presence of leukemia inhibitor factor instead
of basic fibroblast growth factor, etc.) significantly increases
E-cadherin levels and inhibits integrin signaling. Subsequently,
self-renewal and survival of hESCs under mouse ESC culture
conditions becomes less dependent on integrin signaling but more
dependent on E-cadherin signaling.
22 This study suggests that
different growth factors/cytokines modify hESC utilization of
different cell adhesion systems to maintain cell identity. hESCs
may have a broad dynamic range of pluripotent states, likely
regulated by different inputs from the E-cadherin and integrin
and influenced by growth factors.
In addition, controllable overexpression of E-cadherin in
hESCs using a doxycycline-inducible lentiviral system enhances
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the expression of the apoptotic inhibitory gene Bcl-xL, while
suppressing the expression of the pro-apoptotic gene Caspase-3.
63
Consistently, two recent studies showed a significant increase of
survival and colonies in the single-cell suspension cultures after
overexpression of Bcl-xL
89 and Bcl2
90 genes in hESCs. Moreover,
upregulation of E-cadherin expression leads to high clonogenicity
in hESCs while knockdown results in the opposite outcome.
63
Interestingly, E-cadherin-expressing feeder cells promote neural
lineage restriction of hESCs,
11 suggesting that direct E-cadherin
engagement between hESCs and other type of cells may favor
neural specification. It is apparent that the roles of E-cadherin
signaling in hESC self-renewal and lineage specification is far
from simple and in need of further mechanistic investigation.
E-cadherin expression enhances the derivation of induced
pluripotent stem cells. The active role and function of E-cadherin
in the regulation of pluripotent state of ESCs is further demon-
strated in the derivation of iPSCs. Using Yamanaka’s factors
(Oct4, Sox2, Klf4 and c-Myc), Aasen and colleagues
91 have shown
that reprogramming efficiency is 100-fold greater and 2-fold faster
for the conversion of human epithelial cells (keratinocytes that
already express E-cadherin) to hiPSCs than for human fibroblasts.
Bypassing a requirement for mesenchymal-to-epithelial transition
(MET) has been speculated for the high reprogramming efficiency
of epithelial cells, although this hypothesis has yet to be assessed
directly.
In 2010, several research groups independently demonstrated
that undergoing MET is an essential early step of reprogram-
ming
92,93 and E-cadherin is required in the initial stages of this
process.
34,66,92,93 Reprogramming of fibroblasts into hiPSCs is a
slow (2–3 weeks) and inefficient (, 1%) progress in which
somatic cells gradually lose their differentiated identity and
assume embryonic gene expression patterns and growth behaviors.
Several groups have chronologically traced the events that occur
during the first 2–3 weeks upon induction of the reprogramming
factors in mouse embryonic fibroblasts. The first change in gene
expression is the downregulation of somatic markers including
key mesenchymal genes such as Snail and N-cadherin.
92-94 Con-
comitantly, E-cadherin is upregulated when cells undergo a
MET and start proliferating.
92-94 Similar observations have been
reported in reprogramming of human somatic cells.
66 In addition,
ectopic expression of human E-cadherin in mouse embryonic
fibroblasts results in a 4-fold increase in iPSC colonies.
34 In
contrast, E-cadherin knockdown or inhibition reduces the repro-
gramming efficiency of mouse fibroblasts,
34,92,93 human primary
fibroblasts and keratinocytes.
66 Further mechanistic study has
demonstrated that the adhesive binding activity of E-cadherin is
essential for the reprogramming process.
34 Collectively, these data
as well as previous work
62 suggest that E-cadherin is crucial for
the self-renewal of human pluripotent stem cells and reprogramm-
ing of adult cells to iPSCs.
Most recently, Redmer and colleagues have further demon-
strated the importance of E-cadherin in reprogramming.
95 They
found that the forced expression of E-cadherin together with
other three Yamanaka factors (Sox2, Klf4 and c-Myc) was
sufficient to reprogram murine fibroblasts to iPSCs, without the
need of Oct4.
95 Although further testing needs to be done on
human cells, their data suggest the spatial and mechanical input
provided by E-cadherin alters cell fate. E-cadherin may directly
or indirectly tie into the pluripotent transcription factor circuit
thereby influencing the master transcription factor Oct4.
However, considering their different biological activities, it is
unlikely that E-cadherin can functionally replace Oct4. Clearly,
molecular mechanism underlying the cross-talk between cell
surface molecules and nuclear machinery is key to furthering our
understanding of this crucial interaction.
Recent findings have, however, provided some new insights
into this issue. It seems that Oct4 and Sox2 suppress the Snail
(an E-cadherin repressor), Klf4 induces E-cadherin expression,
and c-Myc downregulates the expression of TGF-β1 and TGF-β
receptor 2.
92 It is well known that TGF-β signals induce the
epithelial-to-mesenchymal transition, at least in part, through the
activation of the E-cadherin repressor Snail and thereby negatively
regulate the MET. Furthermore, the crucial role and possible
mechanism of E-cadherin in reprogramming
34,66,92,93 has been
further highlighted by failed rescue experiments with β-catenin.
34
β-catenin is an adaptor molecule that links to the cytoplasmic tail
of E-cadherin mediating cell-cell adhesion and is also a pivotal
effector of the canonical Wnt signaling pathway. It is known that
β-catenin enhances Oct4 activity and plays an important role in
the regulation of self-renewal of ESCs.
96 Unexpectedly, β-catenin
is incapable of rescuing the poor reprogramming efficiency
induced by E-cadherin inhibition,
34 suggesting an indispensable
role of E-cadherin in reprogramming. Finally, microRNAs
(miRNAs) are emerging as critical regulators of cell function
within this network. Using a strategy that avoids the caveats
associated with transient transfection of chemically synthesized
miRNA mimics, Liao and colleagues
97 have shown that miRNA
clusters 302 and 367 target TGFβ receptor 2, promote E-cadherin
expression and accelerate MET necessary for colony formation.
97
Together, these observations have provided important biological
insights into how E-cadherin plays an overarching role in
reprogramming, self-renewal and pluripotency.
The role of N-cadherin and VE-cadherin in human pluri-
potent stem cells. Another two members of classic cadherin
subfamily studied in hESCs are N-cadherin and VE-cadherin.
Similar to E-cadherin, both family members are single-pass trans-
membrane glycoproteins that form Ca
2+-dependent homophilic cis-
and trans-interactionswith their extracellularregions and alsolink to
catenins through their cytoplasmic tails.
98 Unlike E-cadherin,
however, they are not expressed by undifferentiated hESCs.
50,51
The appearance of N-cadherin and VE-cadherin often represent a
specific cell lineage transition differentiated from hESCs.
N-cadherin is expressed by a variety of cell types, including
neuroepithelial cells, neurons, mesenchymal cells,
40 as well as fetal
and adult hepatocytes,
99 but is not expressed by undifferentiated
hESCs.
50,51 N-cadherin has therefore been used as a neuroepithe-
lial marker or a mesenchymal marker in the studies of hESC
differentiation, depending on the status of other co-markers.
During neural induction, hESCs and hiPSCs change their mor-
phology into compactly assembled cells and then into tubular
rosette-like structures expressing neural precursor cell specific
markers such as Pax6, nestin and Sox2.
100 Expression of
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N-cadherin is asymmetrically localized on the luminal side of the
rosettes, a characteristic feature of primitive neuroepithelial rosette
structures.
100-103 An early switch from E-cadherin expression in
undifferentiated hESCs to N-cadherin expression is retained in
rosette-stage neural stem cells.
100,101 This scenario recapitulates
embryonic development in vivo. For instance, during the
formation of the neural tube, E-cadherin is switched off
in a subset of cells, whereas N-cadherin expression is turned on
in those cells.
30 Additionally, N-cadherin is also expressed in
mesodermal tissues.
40 A switch from E-cadherin to N-cadherin
expression, indicating epithelial-to-mesenchymal transition, is
observed in hESC differentiation.
50 Recently, N-cadherin has
also been reported as a surface marker for the enrichment of
hepatic endoderm cells from differentiated hESCs.
99
VE-cadherin, an endothelial-specific cell-cell adhesion protein
of the adherens junction complex, plays a key role in endothelial
barrier function and angiogenesis.
98,104 VE-cadherin is absent in
undifferentiated hESCs but is upregulated prior to hematopoietic
emergence between days 3 and 10 of human embryoid body
(hEB) development.
105 Several studies have identified a popu-
lation of intermediate-stage precursors defined, in part, by their
expression VE-cadherin and other specific surface markers that
possess primitive endothelial properties during hESC differentia-
tion. These precursors are capable of giving rise to endothelial and
hematopoietic cells.
28,105-107 Additionally, screens using green
fluorescent protein driven by VE-cadherin promoter to identify
factors that promote vascular commitment have revealed that the
expansion and maintenance of hESC-derived endothelial cells
by TGFβ inhibition is dependent on Id1 (an inhibitor of a
group of basic helix-loop-helix transcription factors), providing
a further correlative link between VE-cadherin and hESC fate
determination.
108
Cell-Cell Adhesion Molecules in Human Pluripotent
Stem Cells: L1-CAM, NCAM and PECAM-1
The immunoglobulin superfamily (IgSF) is another class of
CAMs. IgSF CAMs are either homophilic or heterophilic and
bind integrins or different IgSF CAMs. IgSF CAMs contain one
or more of the extracellular Ig-like domains characteristic of
antibody molecules.
109 Analysis of the human genome reveals that
this Ig-like domain has the widest representation of any protein
domain, being encoded by 765 genes.
109 Expression and function
of IgSF CAMs in undifferentiated hESCs and hiPSCs have not
been extensively studied. Our knowledge of the expression
patterns or levels and the roles or functions of IgSF CAMs on
hESCs and hiPSCs remain limited. For example, a molecule called
L1-CAM (CD171) that belongs to IgSF CAM family has been
shown to be displayed by undifferentiated hESCs but little is
known about its function.
35 Other IgSF CAM molecules, if
detected, most often appear first during hESC differentiation
into a specific lineage and are thus used as surface markers to
fractionate hESC-derived stage-specific subpopulations. These
molecules include NCAM (Neural Cell Adhesion Molecule/
CD56) and PECAM-1 (Platelet-Endothelial Cell Adhesion
Molecule-1/CD31).
NCAM/CD56 is a homophilic binding glycoprotein. It is the
first member of IgSF CAM family described in the central
nervous system although its expression is also found in other
cell types and not restricted to neural cells. NCAM/CD56 has
been used to isolate hESC-derived neurons by fluorescence
activated cell sorter (FACS) at late stage of neural differentiation
since NCAM does not present on undifferentiated hESCs, neural
stem cells, or neural precursor cells.
110,111 FACS-sorted hESC-
derived neurons survive in vivo after transplantation into the
rodent brain.
110 Furthermore, there is evidence that NCAM/
CD56-positive and CD326 (epithelial cell adhesion/activating
molecule, EpCAM)-negative populations may represent more
lineage-restricted mesodermal progenitors differentiated from
hESCs.
112
PECAM-1/CD31 has been considered to be a marker asso-
ciated with cells with early hematopoietic potential in the human
embryo.
113 PECAM-1/CD31 is undetectable in undifferentiated
hESCs but upregulated prior to hematopoietic emergence
between days 3 and 10 of hESC differentiation.
105 A subset of
embryonic endothelia lacking the common leukocyte marker
CD45 but expressing surface markers PECAM-1/CD31, CD34,
VEGFR2 (vascular endothelial growth factor receptor 2) and
VE-cadherin are first identified within 3–10 d of hEB develop-
ment. These cells have the ability to give rise to both endo-
thelial and hematopoietic cells.
17,105 Subsequent in vivo studies
have shown that these hESC-derived hematopoietic cells possess
hematopoietic stem/progenitor properties after transplantation
into immunodeficient mice.
28 A recent study further reveals
PECAM/CD31-positive cells purified from differentiating EBs
express high levels of ICAM-1 (intercellular adhesion molecule 1)
and VCAM-1 (vascular cell adhesion molecule-1).
107 They also
express multiple endothelial genes and form lumenized vessels
when seeded onto porous poly(2-hydroxyethyl methacrylate)
scaffolds and subcutaneously implanted in athymic rats.
107 Thus,
it is likely that, during early hESC differentiation, the PECAM/
CD31-positive cells may represent primitive endothelium capable
of further development into committed hematopoietic and
endothelial cells.
Cell-Matrix Adhesion Molecules in Human Pluripotent
Stem Cells: Integrins
In addition to cadherin mediated cell-cell adhesion, the main-
tenance of hESCs and hiPSCs also requires contact with
extracellular matrix components. The requirement for basement
membrane formation in human pluripotent stem cells is
consistent with their cellular origin.
1 During embryonic develop-
ment, cells not only interact with each other but also with the
extracellular matrix composed of proteins such as collagen,
fibronectin and laminin that interlace with proteoglycans.
114
hESCs interact with extracellular matrix via cell-surface receptors
including integrins, which allow for mechanically anchoring
to the extracellular substrates as well as intracellular signal
transduction.
Integrins are heterodimeric surface glycoproteins and constitute
a large and widespread family of cell-matrix adhesion molecules.
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There are 24 known integrin heterodimers comprised of
combinations of one of 18 a subunits and one of 8 β subunits.
115
The integrin dimers bind to an array of different extracellular
matrix molecules with overlapping binding affinities.
116
Genomic data (microarray, expressed sequence tags analysis
and massively parallel signature sequencing
27,117,118) have provided
the expression profiles of different integrin subunits in hESCs.
Integrin expression and function in hESCs have also been




18 a subunits and 8 β subunits, a1, a2, a3, a5, a6, a7, a11,
aV, aE and β1, β2, β3, β5 have been detected in undifferentiated
hESCs in the aforementioned reports, albeit with some
controversy. These controversial results have been attributed to
inter-line variation, heterogeneity and/or highly plastic phenotype
of hESCs. Additionally, culture methodologies (e.g., feeder layer
vs. feeder free) and analysis methods vary significantly among
different research groups.
A recent study shows that hiPSC lines reprogrammed by Oct4,
Sox2, Nanog and Lin28 and cultured on Matrigel and vitronectin
express a repertoire of integrins similar to that of hESCs, although
hiPSCs prominently express subunits a5, a6, aV, β1 and β5.
33 It
appears that β1 integrin is required for hiPSC adhesion and
proliferation on Matrigel, while integrin aVβ5 is required for the
initial attachment to vitronectin.
33 Furthermore, integrins aVβ3
and aVβ5 (also mediating hiPSC adhesion to vitronectin) have
been found to contribute to self-renewal and pluripotency
123 and
to the clonal growth
121 of hESCs.
Integrin-related pathways, such as PI3K-Akt
22,24,65 and Mek/
Erk
24,125 also play important role in hESC survival. The PI3K-Akt
pathway has been shown to inhibit apoptosis and attenuate cell
death after hESC dissociation, and constitutive overexpression of
Akt partially improves hESC survival.
65
Cell-Matrix Adhesion Molecules in Human Pluripotent
Stem Cells: Heparan Sulfate Proteoglycans
Heparan sulfate proteoglycans (HSPGs) reside on the plasma
membrane of all animal cells studied to date and are a major
component of extracellular matrices.
126 HSPGs are composed of a
core protein and one or more heparan sulfate glycosaminoglycan
(GAG)-chains. There are three subfamilies of HSPGs: the
membrane-spanning proteoglycans (namely syndecans, betaglycan
and CD44v3), the glycophosphatidylinositol (GPI)-linked pro-
teoglycans (namely glypicans) and the secreted extracellular matrix
proteoglycans (namely agrin, collagen XVIII and perlecan).
HSPGs contain long polysaccharide side chains that bind signal
proteins and immobilize them, by which HSPGs help localize the
action of secreted signal proteins.
127 HSPGs may also control the
stability of signal proteins, transport them through the extra-
cellular space, or make them interact with cell-surface receptors.
For example, the stability, movement and reception of diffusible






133,134 have been reported to be controlled
by HSPGs.
HSPGs are present throughout embryonic development
126,127
and potentially modulate signals essential for the maintenance of
self-renewal or for the initiation of differentiation. Most recently,
Shimokawa et al. revealed that cell surface-tethered heparan
sulfate chains (key components of HSPGs) play pivotal roles in
the local retention of FGF ligands and moreover, can “spread”
FGF signaling to adjacent cells within a short-distance in heparan
sulfate-deficient mouse embryos.
135 However, the functional role
of cell surface-HSPGs in hESCs and hiPSCs has not been
elucidated until recently.
New data showed that secreted HSPGs produced by mouse
embryonic fibroblast feeder cells coordinated hESC prolifera-
tion.
136 It is well known that hESCs can be maintained in an
undifferentiated state if the culture medium is first conditioned
on a layer of mouse embryonic fibroblast feeder. Using column
chromatography, immunoblotting and mass spectrometry-based
proteomic analysis, multiple secreted HSPG species have been
identified in mouse embryonic fibroblast-conditioned medium.
136
These HSPGs and other heparinoids can stabilize basic fibroblast
growth factor (bFGF) and also directly mediate binding of bFGF
to the hESC surface, promoting hESC maintenance. In contrast,
removal of HSPGs from conditioned medium impairs hESC
proliferation,
136 suggesting that HSPGs might be key signaling
cofactors in hESC maintenance. One potential mechanism,
infered from studies of mouse ESCs, could be that heparan
sulfate chains mediate autocrine/paracrine Wnt/β-catenin signal-
ing to regulate Nanog expression,
137 although further validation
will be required in human pluripotent stem cells.
Concluding Remarks
CAMs provide two-way communication links from hESCs (or
hiPSCs) to their surrounding environment and from one cell to
another. CAMs also mediate/regulate the transduction initiated
by many chemical signals across cell membrane and enable con-
nections with important intracellular signaling pathways. The
molecular and cellular biology of CAMs and their functions in
hESCs and hiPSCs represents a very exciting area of discovery
with emerging links to self-renewal, pluripotency, reprogramm-
ing and differentiation. Further understanding the underlying
mechanisms will greatly facilitate the maintenance and direct
differentiation of hESCs and hiPSCs into a given cell type for
potential applications necessary to validate their regenerative
potential. There is little doubt that research into CAMs and
human pluripotent stem cells will continue to produce interesting
and surprising results key to the future cell replacement strategies.
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